Avalo Therapeutics (AVTX) Q2 2023 Earnings

3AugConfirmed
Aug 22
Nov 22
Q4 2022
Q2 2023
-1.77
-1.07
-0.36
0.34

Details

Expected EPS
-0.8
Actual EPS
-0.59
Surprise EPS
0.21
Surprise Percent
+26.25%

Description

Avalo Therapeutics (AVTX) has reported earnings of -0.59 per share for Q2 2023.

0 Comments

Share your thoughts